AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 16 June 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00166-08v1
52/8/2905    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Samuelsen, O.
Right arrow Articles by Spencer, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samuelsen, O.
Right arrow Articles by Spencer, J.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00166-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Kinetic Characterization of VIM-7, A Divergent Member of the VIM Metallo-{beta}-Lactamase-Family

Ørjan Samuelsen*, Mariana Castanheira, Timothy R. Walsh, and James Spencer*

Reference Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway; Department of Cellular and Molecular Medicine, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK; Department of Medical Microbiology, University of Cardiff, Heath Park, Cardiff CF14 4XN, UK; JMI Laboratories, North Liberty, IA 52317, USA

* To whom correspondence should be addressed. Email: orjan.samuelsen{at}unn.no. Jim.Spencer{at}bristol.ac.uk.


   Abstract

Purified recombinant VIM-7 possesses efficient penicillinase and carbapenemase activity comparable to VIM-2. Cephalosporinase activity was variable and generally lower than for VIM-1 or VIM-2. An homology model suggests that the VIM-7 Tyr-218 Phe substitution may be responsible for the reduced catalytic efficiency against certain cephalosporins, including ceftazidime and cefepime.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.